Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Messori

Showing results (1-10 of 264) with videos related to

Pageof 27
Sort By:
ACS Medicinal Chemistry Letters|June 18, 2020
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of AuranofinTiziano Marzo, Luigi Messori
Metal Ions in Biological Systems|June 23, 2004
Gold complexes as antitumor agentsLuigi Messori, Giordana Marcon
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Protein targets for anticancer gold compounds: mechanistic inferencesChiara Gabbiani, Luigi Messori
Inorganic Chemistry|April 4, 2014
Cisplatin binding to proteins: molecular structure of the ribonuclease a adductLuigi Messori, Antonello Merlino
Metal Ions in Life Sciences|February 3, 2018
The Deceptively Similar Ruthenium(III) Drug Candidates KP1019 and NAMI-A Have Different Actions. What Did We Learn in the Past 30 Years?Enzo Alessio, Luigi Messori
Metal Ions in Biological Systems|June 23, 2004
Gold complexes in the treatment of rheumatoid arthritisLuigi Messori, Giordana Marcon
Molecules (Basel, Switzerland)|May 30, 2019
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic ChemistryEnzo Alessio, Luigi Messori
Current Topics in Medicinal Chemistry|November 2, 2011
Molecular mechanisms and proposed targets for selected anticancer gold compoundsAngela Casini, Luigi Messori
Dalton Transactions (Cambridge, England : 2003)|February 21, 2014
Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozymeLuigi Messori, Antonello Merlino
Expert Review of Anticancer Therapy|July 13, 2002
Gold(III) complexes as a new family of cytotoxic and antitumor agentsGiordana Marcon, Luigi Messori, Pierluigi Orioli
Pageof 27

Showing results (1-10 of 264) with videos related to

Sort By:
Pageof 27
ACS Medicinal Chemistry Letters|June 18, 2020
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of AuranofinTiziano Marzo, Luigi Messori
Metal Ions in Biological Systems|June 23, 2004
Gold complexes as antitumor agentsLuigi Messori, Giordana Marcon
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Protein targets for anticancer gold compounds: mechanistic inferencesChiara Gabbiani, Luigi Messori
Inorganic Chemistry|April 4, 2014
Cisplatin binding to proteins: molecular structure of the ribonuclease a adductLuigi Messori, Antonello Merlino
Metal Ions in Life Sciences|February 3, 2018
The Deceptively Similar Ruthenium(III) Drug Candidates KP1019 and NAMI-A Have Different Actions. What Did We Learn in the Past 30 Years?Enzo Alessio, Luigi Messori
Metal Ions in Biological Systems|June 23, 2004
Gold complexes in the treatment of rheumatoid arthritisLuigi Messori, Giordana Marcon
Molecules (Basel, Switzerland)|May 30, 2019
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic ChemistryEnzo Alessio, Luigi Messori
Current Topics in Medicinal Chemistry|November 2, 2011
Molecular mechanisms and proposed targets for selected anticancer gold compoundsAngela Casini, Luigi Messori
Dalton Transactions (Cambridge, England : 2003)|February 21, 2014
Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozymeLuigi Messori, Antonello Merlino
Expert Review of Anticancer Therapy|July 13, 2002
Gold(III) complexes as a new family of cytotoxic and antitumor agentsGiordana Marcon, Luigi Messori, Pierluigi Orioli
Pageof 27